Analyst Price Targets — INO
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| June 1, 2026 10:11 am | — | H.C. Wainwright | $2.50 | $1.31 | TheFly | Inovio price target lowered to $2.50 from $3 at H.C. Wainwright |
| November 14, 2025 1:11 pm | Edward Tenthoff | Piper Sandler | $6.00 | $1.99 | StreetInsider | 'Inovio Pharmaceuticals (INO) Raises $28.75M to Fund Operations'; PT Raised at Piper Sandler |
| August 9, 2024 6:26 am | Gregory Renza | RBC Capital | $8.00 | $8.71 | StreetInsider | Inovio Pharmaceuticals (INO) PT Lowered to $8 at RBC Capital |
| May 14, 2024 10:08 am | Hartaj Singh | Oppenheimer | $40.00 | $11.45 | StreetInsider | Oppenheimer Reiterates Outperform Rating on Inovio Pharmaceuticals (INO) |
| May 13, 2024 4:32 pm | Sudan Loganathan | Stephens | $20.00 | $11.36 | TheFly | Inovio initiated with an Overweight at Stephens |
| January 25, 2024 6:57 am | Hartaj Singh | Oppenheimer | $4.00 | $6.79 | StreetInsider | Oppenheimer Upgrades Inovio Pharmaceuticals (INO) to Outperform |
Latest News for INO
NEW YORK, June 4, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Inovio Pharmaceuticals caused the company to misrepresent or fail to disclose that (i) manufacturing for Inovio's…
Inovio Pharmaceuticals, Inc. (INO) Presents at Jefferies Global Healthcare Conference 2026 Transcript
NEW YORK, June 02, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Inovio Pharmaceuticals caused the company to misrepresent or fail to disclose that (i) manufacturing for Inovio's…
New York, New York--(Newsfile Corp. - June 1, 2026) - Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) breached their fiduciary duties to shareholders. According to a federal securities lawsuit, Insiders at Inovio Pharmaceuticals caused the company to misrepresent or fail to disclose that (i) manufacturing for…
PLYMOUTH MEETING, Pa., May 28, 2026 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in the following scientific and investor conferences: Jefferies Global Healthcare Conference (New York) Date: Thursday, June 4 Time:…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for INO.
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.